Akretive Holdings reports 15.9% stake in cbdMD after asset purchase deal

Akretive Holdings LLC acquired 2,229,805 shares of cbdMD, Inc. common stock on 30 October 2026, according to the Schedule 13D filed on 4 November 2026. The filing states the stake amounts to approximately 15.9% of the 14,048,386 shares of cbdMD common stock outstanding as of 30 October 2026.

The Schedule 13D states the shares were acquired pursuant to an Asset Purchase Agreement dated 1 September 2026 among cbdMD, To Be Brands LLC, Twinlab Consolidated Holdings, Inc., Philip J. Von Kahle in his capacity as the duly appointed assignee for the benefit of creditors, and Akretive Holdings. The agreement, per the filing, provides Akretive with the right to nominate a director for the Nominating and Corporate Governance Committee of cbdMD to consider. The filing also states that Akretive acquired a Senior Secured Promissory Note as part of the same transaction.

The filing identifies Akretive LLC, a Nevada limited liability company, as the Managing Member of Akretive Holdings LLC, a New York limited liability company, and Patrick Ogle as the Managing Member of Akretive LLC. It states that Ogle holds sole power to vote and to dispose of all shares beneficially owned by Akretive Holdings. The filing says neither Akretive Holdings nor Ogle has been convicted in a criminal proceeding or been subject to specified civil judgments or orders in the past five years, and that neither engaged in any transactions in cbdMD shares during the 60 days before the filing other than the transaction described.

SEC EDGAR records show cbdMD also filed an 8-K on 2 September 2026 reporting a material agreement, and a further 8-K on 4 November 2026 reporting an acquisition or disposal and other matters, the same date as the Schedule 13D.

The Schedule 13D does not state whether Akretive Holdings has exercised, or intends to exercise, the right to nominate a director.